. 2014 Dec 12;111(50):847–855. doi: 10.3238/arztebl.2014.0847

Table 3. Definition of high-dose ICS therapy according to ERS/ATS consensus 2014.

	6 to 12 years	>12 years
Beclomethasone	≥800µg^*1	≥2000µg^*1
Beclomethasone	≥320µg^*2	≥1000 µg^*2
Budesonide	≥800µg	≥1600 µg
Ciclesonide	≥160µg^*3	≥320µg
Fluticasone propionate	≥500µg	≥1000µg
Mometasone furoate	≥500µg^*3	≥800µg

Doses shown are total daily doses of inhaled steroids (ICSs) which are classified as high-dose ICS therapy according to the consensus (7) of the European Respiratory Society (ERS) and the American Thoracic Society (ATS). by age group (patients aged 6 to 12 years and those aged over 12 years).

^*1Beclomethasone dose for dry powder inhalers

^*2Beclomethasone for hydrofluoroalkane (HFA) metered-dose inhalers

^*3Not approved for children under 12 in Germany